Humana Stock Price, News & Analysis

Humana Inc. (NYSE: HUM) has successfully completed a $1.25 billion public offering of senior notes. This includes $500 million in 5.750% senior notes due in 2028 and $750 million in 5.875% senior notes due in 2033. The expected net proceeds are approximately $1.232 billion, primarily earmarked for repaying existing senior notes maturing in December 2022 and general corporate purposes. The offerings were managed by BofA Securities, Goldman Sachs, J.P. Morgan, and PNC Capital Markets. The company is subject to various risks, including those linked to healthcare costs and COVID-19 impacts.

Humana Inc. has opened its second CarePlus Community Center in Orlando, Florida, focused on serving Medicare beneficiaries. Following a successful launch in Winter Haven, the new 5,000-square-foot facility offers free health education programs and services to the local community. A recent survey revealed that 85% of respondents would recommend CarePlus Health Plans due to the center’s offerings. The center also supports local residents through various community drives.

CenterWell Senior Primary Care plans to expand in 2023, announcing the opening of 30 to 35 new centers in markets including Virginia, Mississippi, and Indiana, as well as existing states like Louisiana, Texas, and South Carolina. This initiative is part of a joint venture with Welsh, Carson, Anderson & Stowe. CenterWell focuses on providing senior-focused primary care, operating over 220 centers across 11 states, and aims for continued growth of 30-50 centers annually through 2025. The model emphasizes enhanced doctor-patient relationships, improving health outcomes and patient satisfaction.

Humana has been recognized as the leading insurance company for Medicare Advantage plans in 2023 by U.S. News & World Report, excelling in three key categories: overall rating, member experience, and low-premium plan availability.

With 4.9 million members, or 96%, enrolled in plans rated 4 stars and above, Humana emphasizes quality care and customer service. The recognition follows a strong performance in CMS Star ratings, which evaluate plans on a 1-to-5 star scale. Humana’s commitment to enhancing health outcomes for Medicare beneficiaries has helped solidify its top position in the industry.

CenterWell Senior Primary Care is set to launch three new primary care centers in Louisville, Kentucky, enhancing access to senior-focused healthcare. These centers, part of CenterWell's expansion plan, will incorporate a team-based approach to care. With over 220 centers currently operational, they plan to open 30-50 more annually by 2025. A notable community contribution includes $20,000 donated to local non-profits. The first center began operating on October 24, with upcoming openings on November 21 and January 17.

AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana Inc. (HUM) for its $500 million of 5.75% senior unsecured notes due March 1, 2028, and $750 million of 5.875% senior unsecured notes due March 1, 2033. The outlook for the ratings is stable. Proceeds are expected to refinance $1 billion in debt due in December and for general corporate purposes. Humana maintains a financial leverage of 41%, which is in line with industry standards, while targeting a debt-to-capital ratio below 40%.

Humana Inc. (NYSE: HUM) has priced a public offering of $1.25 billion in senior notes, including $500 million of 5.75% notes due 2028 and $750 million of 5.875% notes due 2033. The offering is set to close on November 22, 2022. The expected net proceeds of approximately $1.232 billion will be used to repay existing senior notes due in December 2022 and for general corporate purposes. The offerings are made under an effective shelf registration statement with the SEC.

Humana Inc. (NYSE: HUM) reported 3Q22 GAAP EPS of $9.39 and adjusted EPS of $6.88, with YTD 2022 GAAP EPS at $22.16 and adjusted EPS at $23.58. The company raised FY 2022 guidance to approximately $23.27 GAAP EPS and affirmed an adjusted EPS target of $25.00, showing 21% growth from FY 2021. Humana leads in Medicare Advantage Star ratings, with 96% of members in contracts rated 4 stars or higher. It expects growth of 325,000 to 400,000 Medicare Advantage members in 2023, aligning with industry trends.

Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on January 27, 2023, to stockholders recorded as of the close on December 30, 2022. This decision reflects Humana's commitment to returning value to its shareholders while promoting integrated healthcare solutions through various clinical capabilities. The company continues to prioritize the well-being of its members, which include individuals, families, and military personnel, by simplifying healthcare access and improving quality of life.